Article info
Extended report
The dual inhibitor of lipoxygenase and cyclooxygenase ML3000 decreases the expression of CXCR3 ligands
- Caroline Ospelt, MD, Center of Experimental Rheumatology, University Hospital, Gloriastrasse 25, CH-8091 Zurich, Switzerland; Caroline.Ospelt{at}usz.ch
Citation
The dual inhibitor of lipoxygenase and cyclooxygenase ML3000 decreases the expression of CXCR3 ligands
Publication history
- Accepted July 22, 2007
- First published July 31, 2007.
Online issue publication
March 18, 2008
Article Versions
- Previous version (31 July 2007).
- You are viewing the most recent version of this article.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
2008 BMJ Publishing Group and European League Against Rheumatism